Cancer Contribution
Created in 2015
- BETA
Up & running (A)
Existing signals show a regular activity Social networks
4,318 2,039Activities
Entity types
Location
39 Rue Camille Desmoulins, 94800 Villejuif, France
Villejuif
France
Employees
Scale: 2-10
Estimated: 5
Engaged corporates
13
4 9Added in Motherbase
3 years, 4 months ago
biotech Value proposition
[Automatic translation follows] Actor of democracy in health
Our mission is that each of the actors concerned by cancer (patients, caregivers, doctors, political leaders, researchers, the associative world, citizens), with their expertise, participates in the co-construction of a new vision around the disease and its impacts on society. The new vision resulting from this process is the basis for political proposals and the development of professional practices.
Our objective is twofold:
1/ to bring together for the first time a community of different and complementary experts.
2/ To build together avenues of reflection and propose solutions for the improvement of the health system.
The two essential achievements of Cancer Contribution are the creation in 2011 of the collaborative platform cancercontribution.fr and the CancerAdomR program, resulting from an emblematic study carried out in order to assess and take into account the vision of patients and caregivers on the outpatient shift in the medical management of cancer.Original language
Acteur de démocratie en santé
Notre mission est que chacun des acteurs concernés par le cancer (patients, proches aidants, médecins, responsables politiques, chercheurs, monde associatif, citoyens), avec son expertise, participe à la co-construction d’une nouvelle vision autour de la maladie et de ses impacts sur la société. La nouvelle vision issue de ce processus est la base de propositions politiques et d’élaboration des pratiques professionnelles.
Notre objectif est double :
1/ regrouper pour la première fois une communauté d’experts différents et complémentaires.
2/ Construire ensemble des pistes de réflexion et proposer des solutions pour l’amélioration du système de santé.
Les deux réalisations essentielles de Cancer Contribution sont la création en 2011 de la plateforme collaborative cancercontribution.fr et le programme CancerAdomR, issu d’une étude emblématique réalisée afin d’apprécier et tenir compte de la vision des malades et des soignants sur le virage ambulatoire de la prise en charge médicale du cancer.
Bienvenue sur la Plateforme collaborative Cancer Contribution
Plateforme collaborative de l'association Cancer Contribution pour informer sur les enjeux du cancer. Vous aussi, témoignez pour contribuer !
https://www.cancercontribution.fr/ - Website is disabled or domain is for sale
| Corporate | Type | Tweets | Articles | |
|---|---|---|---|---|
 Daiichi Sankyo Pharmaceutical | Daiichi Sankyo Pharmaceutical | Other 2 Oct 2024 | | |
 Bouygues Construction Construction, Real Estate | Bouygues Construction Construction, Real Estate | Other 2 Oct 2024 | | |
 AG2R LA MONDIALE Insurance, Mutual insurance | AG2R LA MONDIALE Insurance, Mutual insurance | Other 22 Sep 2024 | | |
 | Agence Régionale de Santé Ile-de-France | Other 13 Nov 2023 | | |
 Greater Paris University Hospitals - AP-HP Health, Hospitals and Health Care | Greater Paris University Hospitals - AP-HP Health, Hospitals and Health Care | Other 7 May 2020 | | |
 Gustave Roussy Health, Hospitals and Health Care | Gustave Roussy Health, Hospitals and Health Care | Other 2 Oct 2024 | | |
 Sanofi Pharmaceutical, Pharmaceutical Manufacturing | Sanofi Pharmaceutical, Pharmaceutical Manufacturing | Other 11 Dec 2023 | | |
 Leem Startup accelerator & VC, Pharmaceutical Manufacturing | Leem Startup accelerator & VC, Pharmaceutical Manufacturing | Other 31 Jan 2018 | | |
 Pfizer Pharmaceutical, Pharmaceutical Manufacturing | Pfizer Pharmaceutical, Pharmaceutical Manufacturing | Other 24 Nov 2022 | | |
 Région Ile de France National and local authorities, Government Administration | Région Ile de France National and local authorities, Government Administration | Other 29 Mar 2022 7 Nov 2024 | | |